undefined undefined
NaN.000
NaN.00%
Outlook Therapeutics(OTLK.US):2024年Q2财报实现营收0美元,前值为0美元;每股收益为-1.55美元,前值为-0.52美元,预期...
05-16 06:03
Outlook Therapeutics press release (NASDAQ:OTLK): Q2 net loss attributable to common stockholders of $114.3 million, or $8.01 per basic and diluted share. Adjusted net loss attributable to common stoc...
05-16 05:39
ISELIN, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Na...
04-29 21:00
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Na...
04-16 04:15
Acuity Brands, Inc. (NYSE: AYI) is scheduled to release earnings results for its second quarter, before the opening bell on April 3, 2024.
04-02 21:56
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Tyler Technologies, Inc. (NYSE: TYL).
04-02 20:58
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
04-02 19:14
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.
04-02 01:02
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
04-01 22:46
Outlook Therapeutics was upgraded to "buy" from a previous investment rating of "neutral" by analysts at BTIG. The ratings firm also set a price target of $50 on the OTLK stock. "Based on the results ...
03-28 01:04